Literature DB >> 11960365

A competitive PCR-based method using TCRD, TCRG and IGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia.

C Guidal, E Vilmer, B Grandchamp, H Cavé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11960365     DOI： 10.1038/sj.leu.2402396

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

Review 1.  The clinical relevance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia.

Authors:  J Moppett; G A A Burke; C G Steward; A Oakhill; N J Goulden
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

2.  Size and composition of T-cell receptor delta (TCRD) junctional sequences are not predictive of the sensitivity of clonospecific oligonucleotides designed for detection of minimal residual disease in acute lymphoblastic leukemia.

Authors:  Taku Seriu; Yvonne Stark; Dorothee Erz; Claus R Bartram
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

3.  IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.

Authors:  E Clappier; N Grardel; M Bakkus; J Rapion; B De Moerloose; P Kastner; A Caye; J Vivent; V Costa; A Ferster; P Lutz; F Mazingue; F Millot; D Plantaz; G Plat; E Plouvier; M Poirée; N Sirvent; A Uyttebroeck; K Yakouben; S Girard; N Dastugue; S Suciu; Y Benoit; Y Bertrand; H Cavé
Journal:  Leukemia       Date:  2015-06-08       Impact factor: 11.528

4.  Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial.

Authors:  Carine Domenech; Stefan Suciu; Barbara De Moerloose; Françoise Mazingue; Geneviève Plat; Alina Ferster; Anne Uyttebroeck; Nicolas Sirvent; Patrick Lutz; Karima Yakouben; Martine Munzer; Pierre Röhrlich; Dominique Plantaz; Frederic Millot; Pierre Philippet; Nicole Dastugue; Sandrine Girard; Hélène Cavé; Yves Benoit; Yves Bertrandfor
Journal:  Haematologica       Date:  2014-04-11       Impact factor: 9.941

5.  An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions.

Authors:  E Clappier; M F Auclerc; J Rapion; M Bakkus; A Caye; A Khemiri; C Giroux; L Hernandez; E Kabongo; S Savola; T Leblanc; K Yakouben; G Plat; V Costa; A Ferster; S Girard; O Fenneteau; J M Cayuela; F Sigaux; N Dastugue; S Suciu; Y Benoit; Y Bertrand; J Soulier; H Cavé
Journal:  Leukemia       Date:  2013-09-25       Impact factor: 11.528
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.